APA

Platzbecker U., Symeonidis A., Oliva E. N., Goede J. S., Delforge M., Mayer J., Slama B., Badre S., Gasal E., Mehta B. & Franklin J. (20170928). A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. : Leukemia.

Chicago

Platzbecker U, Symeonidis A, Oliva E N, Goede J S, Delforge M, Mayer J, Slama B, Badre S, Gasal E, Mehta B and Franklin J. 20170928. A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. : Leukemia.

Harvard

Platzbecker U., Symeonidis A., Oliva E. N., Goede J. S., Delforge M., Mayer J., Slama B., Badre S., Gasal E., Mehta B. and Franklin J. (20170928). A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. : Leukemia.

MLA

Platzbecker U, Symeonidis A, Oliva E N, Goede J S, Delforge M, Mayer J, Slama B, Badre S, Gasal E, Mehta B and Franklin J. A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes. : Leukemia. 20170928.